Swiftmerge Acquisition Total Non-Operating Income/Expense 1970-1969 | ANNA

Swiftmerge Acquisition total non-operating income/expense from 1970 to 1969. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
Swiftmerge Acquisition Annual Total Non-Operating Income/Expense
(Millions of US $)
Swiftmerge Acquisition Quarterly Total Non-Operating Income/Expense
(Millions of US $)
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.042B $0.000B
Swiftmerge Acquisition Corp. entered into definitive merger agreement with HDL Therapeutics Inc.
Stock Name Country Market Cap PE Ratio
NPK (NPKI) United States $0.626B 27.85
Performant Healthcare (PHLT) United States $0.245B 0.00
FTAC Emerald Acquisition (FLDD) United States $0.158B 0.00
Insight Acquisition (AMOD) United States $0.023B 0.00
Hanryu Holdings (GITS) South Korea $0.017B 0.00
Pieris Pharmaceuticals (PVLA) United States $0.016B 0.00
LQR House (YHC) United States $0.011B 0.00
ATIF Holdings (ZBAI) China $0.009B 0.00
Lion Electric (LEVGQ) Canada $0.000B 0.00